Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer.1 passage
• 5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma.1 passage
• A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer.1 passage
• A BMI-category distribution pattern of intrinsic and treatment-related prognostic factors in endometrial cancer.1 passage
• A Phase 1 study evaluating AMG 337 in Asian patients with advanced solid tumors.1 passage
• A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer.1 passage
• A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer.1 passage
• A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.1 passage
• A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer.1 passage
• A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.1 passage
• A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy.1 passage
• A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study).1 passage
• A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201).1 passage
• A Phase III study of oral steroid administration versus local steroid injection therapy for the prevention of esophageal stricture after endoscopic submucosal dissection (JCOG1217, Steroid EESD P3).1 passage
• A Phase III trial of a single early intravesical instillation of pirarubicin to prevent bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403, UTUC THP Phase III).1 passage
• A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.1 passage
• A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.1 passage
• A comparison of liquid-based and conventional cytology using data for cervical cancer screening from the Japan Cancer Society.1 passage
• A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC.1 passage
• A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy.1 passage
• A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapy.1 passage
• A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients.1 passage
• A grading system for predicting the prognosis of gastric cancer with liver metastasis.1 passage
• A histological positive margin after surgery is correlated with high local re-recurrence rate in patients with recurrent myxofibrosarcoma.1 passage
• A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.1 passage
• A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.1 passage
• A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914.1 passage
• A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study).1 passage
• A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1916 (J-PORT study).1 passage
• A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer.1 passage
• A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class.1 passage
• A multicenter non-randomized phase III study of sentinel node navigation surgery for early gastric cancer.1 passage
• A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study).1 passage
• A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer.1 passage
• A nationwide survey of fatigue in cancer patients in Taiwan: an unmet need.1 passage
• A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.1 passage
• A new score for screening of malnutrition in patients with inoperable gastric adenocarcinoma.1 passage
• A non-randomized confirmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer: Japan Clinical Oncology Group Study (JCOG1203).1 passage
• A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A>T (Asp603Val).1 passage
• A novel deletion in the splice donor site of MLH1 exon 6 in a Japanese colon cancer patient with Lynch syndrome.1 passage
• A novel germline BMPR1A variant (c.72_73delGA) in a Japanese family with hereditary mixed polyposis syndrome.1 passage
• A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.1 passage
• A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy.1 passage
• A phase 1 study of ramucirumab in Japanese patients with advanced solid tumors.1 passage
• A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia.1 passage
• A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma.1 passage
• A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for locally recurrent rectal cancer: Japan Clinical Oncology Group study JCOG1801 (RC-SURVIVE study).1 passage
• A phase III trial to confirm modified S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, BIRDIE).1 passage
• A pooled analysis of primary hepatic angiosarcoma.1 passage
• A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan.1 passage
• A prediction model of survival for patients with bone metastasis from uterine corpus cancer.1 passage
• A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer.1 passage
• A preliminary study of the effectiveness of cancer communication skills training for interdisciplinary staff.1 passage
• A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.1 passage
• A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.1 passage
• A prophylaxis study of acute exacerbation of interstitial pneumonia after lung cancer surgery.1 passage
• A prospective cohort study on the safety and efficacy of bevacizumab combined with chemotherapy in Japanese patients with relapsed ovarian, fallopian tube or primary peritoneal cancer.1 passage
• A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients.1 passage
• A prospective multicenter study of intermittent chemotherapy with docetaxel and prednisolone for castration-resistant prostate cancer.1 passage
• A prospective multicentre feasibility study of stereotactic body radiotherapy in Japanese patients with spinal metastases.1 passage
• A prospective study on the efficacy of two-dose influenza vaccinations in cancer patients receiving chemotherapy.1 passage
• A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).1 passage
• A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).1 passage
• A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial).1 passage
• A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413).1 passage
• A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409.1 passage
• A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial).1 passage
• A randomized controlled Phase II/III study comparing endoscopic balloon dilation combined with steroid injection versus radial incision and cutting combined with steroid injection for refractory anastomotic stricture after esophagectomy: Japan Clinical Oncology Group Study JCOG1207.1 passage
• A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study).1 passage
• A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study).1 passage
• A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study.1 passage
• A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311).1 passage
• A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study).1 passage
• A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).1 passage
• A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.1 passage
• A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients.1 passage
• A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup.1 passage
• A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study.1 passage
• A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors.1 passage
• A review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancers.1 passage
• A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).1 passage
• A review of prognostic scores after liver resection in hepatocellular carcinoma: the MSKCC, SLICER and SSCLIP scores.1 passage
• A review of the AJCC melanoma staging system in the TNM classification (eighth edition).1 passage
• A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.1 passage
• A simple home-based self-monitoring tool for early detection of hand-foot syndrome in cancer patients.1 passage
• A single-arm study evaluating bevacizumab, cisplatin, and paclitaxel followed by single-agent bevacizumab in Japanese patients with advanced cervical cancer.1 passage
• A single-center study on predicting outcomes of primary androgen deprivation therapy for prostate cancer using the Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score.1 passage
• A survey about further work-up for cases with positive sputum cytology during lung cancer mass screening in Ishikawa Prefecture, Japan: a retrospective analysis about quality assurance of lung cancer screening.1 passage
• A systematic literature review of prognostic factors in patients with HR+/HER2- advanced breast cancer in Japan.1 passage
• ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.1 passage
• Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.1 passage
• Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab.1 passage
• Accelerated partial breast irradiation by brachytherapy: present evidence and future developments.1 passage
• Accessibility to surgical robot technology and prostate-cancer patient behavior for prostatectomy.1 passage
• Accuracy of using Diagnosis Procedure Combination administrative claims data for estimating the amount of opioid consumption among cancer patients in Japan.1 passage
• Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma.1 passage
• Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association.1 passage
• Acute kidney injury after platinum-based transcatheter arterial chemoembolization and transarterial infusion chemotherapy in patients with hepatocellular carcinoma.1 passage
• Adenocarcinoma arising at a colostomy site with inguinal lymph node metastasis: report of a case.1 passage
• Adequacy evaluation of the annual colonoscopic surveillance and individual difference of disease phenotypes in Lynch syndrome.1 passage
• Adherence to oral chemotherapy medications among gastroenterological cancer patients visiting an outpatient clinic.1 passage
• Adjuvant and neoadjuvant chemotherapy for osteosarcoma: JCOG Bone and Soft Tissue Tumor Study Group.1 passage
• Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.1 passage
• Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.1 passage
• Adjuvant and neoadjuvant therapy for breast cancer.1 passage
• Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma.1 passage
• Adjuvant radiotherapy for cervical cancer in South Korea: a radiation oncology survey of the Korean Radiation Oncology Group (KROG 20-06).1 passage
• Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.1 passage
• Adjuvant treatment for post-operative head and neck squamous cell carcinoma.1 passage
• Adjuvant treatment of endometrial cancer today.1 passage
• Advance care planning in Asian culture.1 passage
• Advancements of liver transplantation for hepatocellular carcinoma in Korea.1 passage
• Alterations in emotional responses (pleasantness/unpleasantness) induced by sniffing food odors during chemotherapy in patients with lung cancer.1 passage
• An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.1 passage
• An epidermal growth factor receptor exon 19 mutation in a mucin-producing gastric cancer sample from a Chinese patient.1 passage
• An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION.1 passage
• An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013.1 passage
• Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era.1 passage
• Analysis of the patients with soft tissue sarcoma who received additional excision after unplanned excision: report from the Bone and Soft Tissue Tumor Registry in Japan.1 passage
• Anatomic-histologic study of the floor of the mouth: the lingual lymph nodes.1 passage
• Anticancer drugs during pregnancy.1 passage
• Antitumor activity of iNGR-GRIM-19 in colorectal cancer.1 passage
• Anxiety in disease-free breast cancer patients might be alleviated by provision of psychological support, not of information.1 passage
• Application of quality control circle in the treatment of moderate cancer pain in inpatients.1 passage
• Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.1 passage
• Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study.1 passage
• Are hospital cancer caseloads related to the validity of staging data reported? A lesson from National Cancer Registry in Taiwan.1 passage
• Are hospitals in Japan with larger patient volume treating younger and earlier-stage cancer patients? An analysis of hospital-based cancer registry data in Japan.1 passage
• Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer.1 passage
• Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data.1 passage
• Assessment of quality of life of children and adolescents with cancer during their treatment.1 passage
• Association between PD-L1 status and immune checkpoint inhibitor response in advanced malignancies: a systematic review and meta-analysis of overall survival data.1 passage
• Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.1 passage
• Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.1 passage
• Association between cancer immunity and treatment results in uterine cervical cancer patients treated with radiotherapy.1 passage
• Association between poorly differentiated clusters and efficacy of 5-fluorouracil-based adjuvant chemotherapy in stage III colorectal cancer.1 passage
• Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013.1 passage
• Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma.1 passage
• Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey.1 passage
• Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads.1 passage
• Attitudes towards second opinion services in cancer care: a nationwide survey of oncologists in Korea.1 passage
• Availability of tissue rinse liquid-based cytology for the rapid diagnosis of sentinel lymph node metastasis and improved bilateral detection by photodynamic eye camera.1 passage
• Awareness about past diagnosis and treatment history: nationwide survey of childhood cancer survivors and their parents.1 passage
• BRAF V600E as an accurate marker to complement fine needle aspiration (FNA) cytology in the guidance of thyroid surgery in the Chinese population: evidence from over 1000 consecutive FNAs with follow-up.1 passage
• BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.1 passage
• Bacillus Calmette-Guérin may have clinical benefit for glandular or squamous differentiation in non-muscle invasive bladder cancer patients: retrospective multicenter study.1 passage
• Barriers to end-of-life discussion with advanced cancer patient as perceived by oncologists, certified/specialized nurses in cancer nursing and medical social workers.1 passage
• Baseline risk stratification or duration of prior therapy predicts prognosis in patients with metastatic renal cell carcinoma treated with axitinib.1 passage
• Benefit of surgical resection of distant metastasis in soft tissue sarcoma: a systematic review.1 passage
• Bevacizumab safety in Japanese patients with colorectal cancer.1 passage
• Biological markers of invasive breast cancer.1 passage
• Biomarker discordance between primary breast cancer and bone or bone marrow metastases.1 passage
• Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future.1 passage
• Body mass index at diagnosis is associated with survival outcome in peripheral T-cell lymphoma: a study of Chinese population.1 passage
• Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas.1 passage
• Bone metastasis of limb segments: Is mesometastasis another poor prognostic factor of cancer patients?1 passage
• Breakthrough pain management using fentanyl buccal tablet (FBT) in combination with around-the-clock (ATC) opioids based on the efficacy and safety of FBT, and its relationship with ATC opioids: results from an open-label, multi-center study in Japanese cancer patients with detailed evaluation.1 passage
• Breast cancer subtypes affect the ultrasound performance for axillary lymph node status evaluation after neoadjuvant chemotherapy: a retrospective analysis.1 passage
• Brief collaborative care intervention to reduce perceived unmet needs in highly distressed breast cancer patients: randomized controlled trial.1 passage
• Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice.1 passage
• Brigatinib and lorlatinib: their effect on ALK inhibitors in NSCLC focusing on resistant mutations and central nervous system metastases.1 passage
• CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapy.1 passage
• CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.1 passage
• Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.1 passage
• Can regular follow-up imaging contribute to the determination of appropriate timing of surgery in patients with undiagnosed mucinous cystic neoplasm? A multicenter retrospective study.1 passage
• Cancer Care Evaluation Scale (CCES): measuring the quality of the structure and process of cancer care from the perspective of patients with cancer.1 passage
• Cancer among children, adolescents and young adults in the Hokushin region, Japan, between 2010 and 2015.1 passage
• Cancer emerging from the recurrence of sessile serrated adenoma/polyp resected endoscopically 5 years ago.1 passage
• Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.1 passage
• Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan.1 passage
• Cancer stem cells in relation to treatment.1 passage
• Cancer survivorship: current status of research, care, and policy in Japan.1 passage
• Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer.1 passage
• Cancer-related pain: a nationwide survey of patients' treatment modification and satisfaction in Taiwan.1 passage
• Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.1 passage
• Cardiac paraganglioma with a novel germline mutation of succinate dehydrogenase gene D.1 passage
• Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.1 passage
• Cardiology consultation in oncology practice: a 5-year survey.1 passage
• Cardiovascular toxic effects of targeted cancer therapy.1 passage
• Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset.1 passage
• Cervical epidural hematoma in a healthy donor presenting stroke mimic symptoms: a rare adverse event following peripheral blood stem cell apheresis.1 passage
• Cervical laser vaporization for women with cervical intraepithelial neoplasia-3.1 passage
• Cessation of long-term adjuvant androgen deprivation therapy after radical prostatectomy: is it feasible?1 passage
• Challenges needed to be overcome in multi-institutional surgical trials: accumulated experience in the JCOG Colorectal Cancer Study Group (CCSG).1 passage
• Challenges of improving treatment outcomes for colorectal and anal cancers in Japan: the Colorectal Cancer Study Group (CCSG) of the Japan Clinical Oncology Group (JCOG).1 passage
• Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study.1 passage
• Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.1 passage
• Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients.1 passage
• Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma.1 passage
• Characteristics of cancer patients who died by suicide in the Tokyo metropolitan area.1 passage
• Characteristics of cellular composition in malignant pericardial effusion and its association with the clinical course of carcinomatous pericarditis.1 passage
• Characteristics of genomic alterations in Chinese cholangiocarcinoma patients.1 passage
• Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution.1 passage
• Characterization of genomic alterations in Chinese colorectal cancer patients.1 passage
• Chemo-selection with docetaxel, cisplatin and 5-fluorouracil (TPF) regimen followed by radiation therapy or surgery for pharyngeal and laryngeal carcinoma.1 passage
• Chemoradiotherapy for esophageal squamous cell cancer.1 passage
• Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities.1 passage
• Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients.1 passage
• Chemotherapy for hepatocellular carcinoma: current status and future perspectives.1 passage
• Cigarette smoking and bladder cancer risk: an evaluation based on a systematic review of epidemiologic evidence in the Japanese population.1 passage
• Cigarette smoking and cervical cancer risk: an evaluation based on a systematic review and meta-analysis among Japanese women.1 passage
• Cigarette smoking and the risk of head and neck cancer in the Japanese population: a systematic review and meta-analysis.1 passage
• Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia.1 passage
• Classification of adult diffuse gliomas by molecular markers-a short review with historical footnote.1 passage
• Clinical and pathological analysis of companion diagnostic testing of microsatellite instability-high for pembrolizumab in gynaecologic malignancy.1 passage
• Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.1 passage
• Clinical benefits of vessel sealing system (LigaSure™) during surgery for soft tissue sarcoma: a propensity score matching analysis.1 passage
• Clinical efficacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib.1 passage
• Clinical efficacy and safety of different doses of intrathecal methotrexate in the treatment of leptomeningeal carcinomatosis: a prospective and single-arm study.1 passage
• Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902).1 passage
• Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.1 passage
• Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study.1 passage
• Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).1 passage
• Clinical impact of renal impairment on the safety and efficacy of S-1 plus oxaliplatin in patients with advanced gastric cancer: a single institutional study.1 passage
• Clinical implication of psoas muscle mass measurement for predicting death within 3 months in patients with incurable uterine cervical or corpus malignancy.1 passage
• Clinical outcome in patients who underwent amputation due to extremity soft tissue sarcoma: Tokai Musculoskeletal Oncology Consortium study.1 passage
• Clinical outcome of definitive radiation therapy for superficial esophageal cancer.1 passage
• Clinical outcome of high dose rate brachytherapy with external beam radiotherapy for high-risk prostate cancer: a single institutional retrospective study.1 passage
• Clinical outcomes and prognostic factors of chemoradiotherapy for postoperative lymph node recurrence of esophageal cancer.1 passage
• Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.1 passage
• Clinical outcomes of endoprosthetic reconstruction for proximal femoral resection.1 passage
• Clinical outcomes of stereotactic ablative radiotherapy in patients with pulmonary metastasis.1 passage
• Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan.1 passage
• Clinical prediction of solitary pulmonary nodule after a curative resection for gastric cancer.1 passage
• Clinical predictors for high-grade bladder cancer before first-time transurethral resection of the bladder tumor: a retrospective cohort study.1 passage
• Clinical relevance of addition of conventional treatment to concurrent chemoradiotherapy in patients with FIGO stage III-IV cervical cancer: a retrospective analysis of a Japanese cohort.1 passage
• Clinical results of definitive intensity-modulated radiation therapy for oropharyngeal cancer: retrospective analysis of treatment efficacy and safety.1 passage
• Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma.1 passage
• Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy.1 passage
• Clinical significance of adding 3 Tesla MRI to the algorithm for decision making on neurovascular bundle preservation in radical prostatectomy.1 passage
• Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.1 passage
• Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.1 passage
• Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer.1 passage
• Clinical significance of tumour mutation burden in immunotherapy across multiple cancer types: an individual meta-analysis.1 passage
• Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).1 passage
• Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.1 passage
• Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.1 passage
• Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients.1 passage
• Clinicopathological characteristics of lung cancer mimicking organizing pneumonia on computed tomography-a novel radiological entity of pulmonary malignancy.1 passage
• Clinicopathological features and oncological outcomes of urothelial carcinoma involving the ureterovesical junction.1 passage
• Clinicopathological features of classical Hodgkin lymphoma in patients ≥ 40 years old, with special reference to composite cases.1 passage
• Co-operative groups in the development of chemotherapy for gastric cancer.1 passage
• Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population.1 passage
• Coffee, green tea and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.1 passage
• Cognitive dysfunction among newly diagnosed older patients with hematological malignancy: frequency, clinical indicators and predictors.1 passage
• Collaboration between EORTC and JCOG-how to accelerate global clinical research partnership.1 passage
• Collaborative care intervention for the perceived care needs of women with breast cancer undergoing adjuvant therapy after surgery: a feasibility study.1 passage
• Colonoscopic evaluation of diarrhea/colitis occurring as an immune-related adverse event.1 passage
• Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis.1 passage
• Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinoma.1 passage
• Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: an updated systematic review and meta-analysis.1 passage
• Combined sleeve lobectomy for centrally located primary lung cancer and lung cancer with hilar lymph node metastasis.1 passage
• Common carotid artery ligation at the proximal side before rupture in patients with ligation or occlusion of the external carotid artery at risk of carotid blowout syndrome.1 passage
• Comorbid insomnia among breast cancer survivors and its prediction using machine learning: a nationwide study in Japan.1 passage
• Comparative risks for cancer associated with use of calcitonin, bisphosphonates or selective estrogen receptor modulators among osteoporosis patients: a population-based cohort study.1 passage
• Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection.1 passage
• Comparing docetaxel plus cisplatin versus fluorouracil plus cisplatin in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.1 passage
• Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A).1 passage
• Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.1 passage
• Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma.1 passage
• Comparison of clinical features and outcomes of patients with leiomyosarcoma of bone and soft tissue: a population-based cohort study.1 passage
• Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.1 passage
• Comparison of clinical outcomes between enucleation and regular pancreatectomy in patients with non-functional pancreatic neuroendocrine tumors: a retrospective multicenter and propensity score-matched study.1 passage
• Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).1 passage
• Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.1 passage
• Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.1 passage
• Comparison of lymphatic complications between sentinel node navigation surgery and pelvic lymphadenectomy in patients with cervical cancer.1 passage
• Comparison of radio-isotope method with 99m technetium and near-infrared fluorescent imaging with indocyanine green for sentinel lymph node detection in endometrial cancer.1 passage
• Comparison of radiotherapy infrastructure between Korea and Japan.1 passage
• Comparison of salvage surgery for recurrent or residual head and neck squamous cell carcinoma.1 passage
• Comparison of survival outcomes between laparoscopic and open surgery in patients with low-risk endometrial cancer.1 passage
• Comparison of the accuracy and characteristics of the prognostic prediction of survival of identical terminally ill cancer patients by oncologists and palliative care physicians.1 passage
• Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor.1 passage
• Comparison of two measures for Complicated Grief: Brief Grief Questionnaire (BGQ) and Inventory of Complicated Grief (ICG).1 passage
• Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.1 passage
• Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma.1 passage
• Comprehensive analysis of DNA mismatch repair-deficient gastric cancer in a Japanese hospital-based population.1 passage
• Comprehensive geriatric assessment is correlated to overall survival among gynaecologic oncology patients.1 passage
• Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China.1 passage
• Conditions, possibility and priority for admission into inpatient hospice/palliative care units in Japan: a nationwide survey.1 passage
• Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy.1 passage
• Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study.1 passage
• Construction and validation of a simple scoring system for stage III colorectal cancer recurrence (SiS-SCORE). A case control study.1 passage
• Controversies in relation to neck management in N0 early oral tongue cancer.1 passage
• Correlation between blood cell count and outcome of melanoma patients treated with anti-PD-1 antibodies.1 passage
• Correlation between the changes in the EPIC QOL scores and the dose-volume histogram parameters in high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for prostate cancer.1 passage
• Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia.1 passage
• Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study.1 passage
• Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer.1 passage
• Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).1 passage
• Cost-effectiveness analysis of enzalutamide for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer in Japan.1 passage
• Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in Japan.1 passage
• Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial.1 passage
• Coverage of the hospital-based cancer registries and the designated cancer care hospitals in Japan.1 passage
• Cryobiopsy during flex-rigid pleuroscopy: an emerging alternative biopsy method in malignant pleural mesothelioma. A comparative study of pathology.1 passage
• Cumulative cigarette tar exposure and lung cancer risk among Japanese smokers.1 passage
• Cumulative incidence, risk factors and prognostic impact of venous thromboembolism in Japanese patients with advanced gastric cancer.1 passage
• Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain.1 passage
• Current and future molecular profiling of cancer by next-generation sequencing.1 passage
• Current approach and future perspective for ductal carcinoma in situ of the breast.1 passage
• Current approaches and future perspectives for advanced-stage follicular lymphoma with a low tumor burden.1 passage
• Current clinical practice of adjuvant chemotherapy for patients with 'high-risk' Stage II colorectal cancer in Japan: a questionnaire survey in the JCOG Study Group.1 passage
• Current indications of endoscopic submucosal dissection for early gastric cancer in Japan.1 passage
• Current status and future perspectives of immunotherapy against urothelial and kidney cancer.1 passage
• Current status and perspectives of immune checkpoint inhibitors for colorectal cancer.1 passage
• Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer.1 passage
• Current status of cancer immunotherapy for gynecologic malignancies.1 passage
• Current status of immunotherapy for advanced gastric cancer.1 passage
• Current status of immunotherapy.1 passage
• Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitals.1 passage
• Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives.1 passage
• Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives.1 passage
• Cutaneous metastasis of renal pelvic urothelial carcinoma mimicking cutaneous angiosarcoma.1 passage
• Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients.1 passage
• Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resection.1 passage
• DASC-21: a novel geriatric assessment for discriminating best supportive care in older patients with inoperable advanced non-small cell lung cancer.1 passage
• DNA methyltransferase-3 like protein expression in various histological types of testicular germ cell tumor.1 passage
• De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.1 passage
• DeCoP, a Dermatitis Control Program using a moderately absorbent surgical pad for head and neck cancer patients receiving radiotherapy: a retrospective analysis.1 passage
• Death by suicide, other externally caused injuries and cardiovascular diseases within 6 months of cancer diagnosis (J-SUPPORT 1902).1 passage
• Debulking surgery for malignant tumors: the current status, evidence and future perspectives.1 passage
• Decrease in tumor enhancement on contrast-enhanced CT is associated with improved survival in patients with hepatocellular carcinoma treated with Sorafenib.1 passage
• Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma.1 passage
• Definitive radiation therapy in patients with unresectable desmoid tumors: a systematic review.1 passage
• Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM.1 passage
• Degarelix as a neoadjuvant hormonal therapy for acute urinary tract toxicity associated with external beam radiotherapy for intermediate- and high-risk prostate cancer: a propensity score matched analysis.1 passage
• Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018.1 passage
• Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study.1 passage
• Developing a nomogram for predicting intravesical recurrence after radical nephroureterectomy: a retrospective cohort study of mainland Chinese patients.1 passage
• Development and psychometric evaluation of a Persian version of the Death Depression Scale-Revised: a cross-cultural adaptation for patients with advanced cancer.1 passage
• Development and validation of a Super learner-based model for predicting survival in Chinese Han patients with resected colorectal cancer.1 passage
• Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy.1 passage
• Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer.1 passage
• Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients of colorectal cancer.1 passage
• Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.1 passage
• Development of cell-cycle checkpoint therapy for solid tumors.1 passage
• Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.1 passage
• Development of targeted therapy and immunotherapy for treatment of small cell lung cancer.1 passage
• Diagnosis and outcome of resected solitary pulmonary nodules after liver transplantation.1 passage
• Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial.1 passage
• Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.1 passage
• Diagnostic value of rapid on-site evaluation during transbronchial biopsy for peripheral lung cancer.1 passage
• Difference of patient's perceived need in breast cancer patients after diagnosis.1 passage
• Differences in baseline risk estimated by physicians and patients with early breast cancer.1 passage
• Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study.1 passage
• Differences of cyclin-dependent kinase 4/6 inhibitor, palbociclib and abemaciclib, in breast cancer.1 passage
• Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.1 passage
• Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.1 passage
• Diffusion kurtosis imaging and tumour microstructure for monitoring response to radiotherapy in human nasopharyngeal carcinoma xenografts.1 passage
• Discomfort during bronchoscopy performed after endobronchial intubation with fentanyl and midazolam: a prospective study.1 passage
• Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.1 passage
• Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.1 passage
• Distress from changes in physical appearance and support through information provision in male cancer patients.1 passage
• Distribution and clinical significance of circulating tumor cells in nasopharyngeal carcinoma.1 passage
• Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer.1 passage
• Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association.1 passage
• Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experience.1 passage
• Docetaxel for platinum-refractory advanced thymic carcinoma.1 passage
• Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?1 passage
• Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.1 passage
• Does fluid collection impact radiotherapy outcomes after wide excision of lower extremity soft tissue sarcoma?1 passage
• Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC).1 passage
• Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer.1 passage
• Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report.1 passage
• Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene.1 passage
• Drug review: Pazopanib.1 passage
• Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma.1 passage
• EML4-ALK, a potential therapeutic target that responds to alectinib in ovarian cancer.1 passage
• Early detection of bone metastases of hepatocellular carcinoma reduces bone fracture and paralysis.1 passage
• Early hepatocellular carcinoma as a signaling lesion for subsequent malignancy.1 passage
• Effect of chemotherapy alone with adult chemotherapy regimens on prognosis of children and adolescents with Hodgkin's disease.1 passage
• Effect of continuous intravenous oxycodone infusion in opioid-naïve cancer patients with dyspnea.1 passage
• Effect of increased expression of both ras-related C3 botulinum toxin substrate 1 and p21-activated kinase 1 in patients with N0M0 upper urinary tract urothelial carcinoma and cancer-free surgical margins.1 passage
• Effect of liver cirrhosis on metastasis in colorectal cancer patients: a nationwide population-based cohort study.1 passage
• Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study.1 passage
• Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.1 passage
• Effect of olanzapine for breast cancer patients resistant to triplet antiemetic therapy with nausea due to anthracycline-containing adjuvant chemotherapy.1 passage
• Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.1 passage
• Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study.1 passage
• Effectiveness of a brief psycho-oncology training program for general nurses: a preliminary study.1 passage
• Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.1 passage
• Effectiveness of planned surveillance for detecting second primary head and neck cancers after endoscopic resection of esophageal squamous cell carcinoma.1 passage
• Effectiveness of rapid titration with intravenous administration of oxycodone injection in advanced cancer patients with severe pain.1 passage
• Effects and safety of mechanical bathing as a complementary therapy for terminal stage cancer patients from the physiological and psychological perspective: a pilot study.1 passage
• Effects of Helicobacter pylori eradication on gastric cancer incidence in the Japanese population: a systematic evidence review.1 passage
• Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis.1 passage
• Effects of adjuvant radiation therapy on survival for patients with resected primary tracheal carcinoma: an analysis of the National Cancer Database.1 passage
• Effects of psoas major muscle volume in predicting the prognosis of patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.1 passage
• Effects of serum estradiol and progesterone on estrogen-regulated gene expression in breast cancers of premenopausal patients.1 passage
• Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.1 passage
• Efficacy and safety comparison of nabpaclitaxel plus S-1 and gemcitabine plus S-1 as first-line chemotherapy for metastatic pancreatic cancer.1 passage
• Efficacy and safety of TC dose-dense chemotherapy as first-line treatment of epithelial ovarian cancer: a single-institution retrospective cohort study.1 passage
• Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study.1 passage
• Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study.1 passage
• Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study.1 passage
• Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study.1 passage
• Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial.1 passage
• Efficacy and safety of docetaxel and prednisolone for castration-resistant prostate cancer: a multi-institutional retrospective study in Japan.1 passage
• Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer.1 passage
• Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan.1 passage
• Efficacy and safety of osimertinib in a Japanese compassionate use program.1 passage
• Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesothelioma.1 passage
• Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial.1 passage
• Efficacy and safety of stereotactic body radiotherapy using CyberKnife in Stage I primary lung tumor.1 passage
• Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain.1 passage
• Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study).1 passage
• Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study.1 passage
• Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation study.1 passage
• Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history.1 passage
• Efficacy of a hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer.1 passage
• Efficacy of afatinib treatment for lung adenocarcinoma harboring exon 18 delE709_T710insD mutation.1 passage
• Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial).1 passage
• Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.1 passage
• Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).1 passage
• Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.1 passage
• Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study.1 passage
• Efficacy of heparinoid moisturizer as a prophylactic agent for radiation dermatitis following radiotherapy after breast-conserving surgery: a randomized controlled trial.1 passage
• Efficacy of immediate-release oxycodone for dyspnoea in cancer patient: cancer dyspnoea relief (CDR) trial.1 passage
• Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.1 passage
• Efficacy of radiotherapy for primary tumor in patients with unresectable pancreatic neuroendocrine tumors.1 passage
• Efficacy of reduced dose of pegfilgrastim in Japanese breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide therapy.1 passage
• Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer.1 passage
• Efficacy of tapentadol for first-line opioid-resistant neuropathic pain in Japan.1 passage
• Efficacy, late complications, and cosmetic outcomes of targeted intraoperative radiotherapy in breast-conserving surgery for early-stage breast cancer: a single-centre study in China.1 passage
• Efficiency and safety of TachoSil® in the treatment of postoperative air leakage following pulmonary surgery: a meta-analysis of randomized controlled trials.1 passage
• Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer.1 passage
• Elotuzumab-induced interstitial lung disease: the first case report.1 passage
• Emerging technologies for cervical cancer screening.1 passage
• End-of-life care for cancer patients in Japanese acute care hospitals: A nationwide retrospective administrative database survey.1 passage
• Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.1 passage
• Epidemiological analysis of childhood cancer in Japan based on population-based cancer registries, 1993-2009.1 passage
• Epidemiology and treatment of hepatocellular carcinoma in Thailand.1 passage
• Epidemiology, tumor characteristics and survival in patients with angiosarcoma in the United States: a population-based study of 4537 cases.1 passage
• Epithelioid hemangioendothelioma of the lung: CT findings and clinical course of 35 cases.1 passage
• Essential competences for psychologists in palliative cancer care teams.1 passage
• Establishing an endoscopic diagnostic process system (M-system) for gastric MALT lymphoma of superficial-spreading type.1 passage
• Establishing metastatic patient-derived xenograft model for colorectal cancer.1 passage
• Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone.1 passage
• Establishment of a research policy for supportive and palliative care in Japan.1 passage
• Estimation of lifetime cumulative incidence and mortality risk of gastric cancer.1 passage
• Estimation of lifetime cumulative mortality risk of lung cancer by smoking status in Japan.1 passage
• Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression.1 passage
• Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in Japan.1 passage
• Evaluation of high-dose cytarabine in induction therapy for children with de novo acute myeloid leukemia: a study protocol of the Japan Children's Cancer Group Multi-Center Seamless Phase II-III Randomized Trial (JPLSG AML-12).1 passage
• Evaluation of histological specimens obtained by two types of EBUS-TBNA needles: a comparative study.1 passage
• Evaluation of oral care to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (Oral Care-BC): randomized controlled phase III trial.1 passage
• Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional study.1 passage
• Evaluation of prognostic factors after radical prostatectomy in pT3b prostate cancer patients in Japanese population.1 passage
• Evaluation of quality indicators near death in older adult cancer decedents in Japan: A nationwide retrospective cohort study.1 passage
• Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.1 passage
• Evaluation of safety and diagnostic performance for flexible hysteroscopy in 1591 outpatient cases.1 passage
• Evaluation of solid portions in non-small cell lung cancer-the solid part is not always measurable for clinical T factor.1 passage
• Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma.1 passage
• Evidence-based cancer prevention recommendations for Japanese.1 passage
• Exercise for physical fitness, fatigue and quality of life of patients undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.1 passage
• Expectations of and recommendations for a cancer survivorship guideline in Japan: a literature review of guidelines for cancer survivorship.1 passage
• Experiences and hidden needs of older patients, their families and their physicians in palliative chemotherapy decision-making: a qualitative study.1 passage
• Expression and prognostic significance of NKD2 in ovarian cancer.1 passage
• Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis.1 passage
• Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature.1 passage
• Extensive peritoneal lavage after curative gastrectomy for gastric cancer (EXPEL): study protocol of an international multicentre randomised controlled trial.1 passage
• External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study.1 passage
• External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort.1 passage
• External validation of two web-based postoperative nomograms predicting the probability of early biochemical recurrence after radical prostatectomy: a retrospective cohort study.1 passage
• Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.1 passage
• FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients.1 passage
• Facial flushing after alcohol intake as a predictor for a high risk of synchronous or metachronous cancer of the upper gastrointestinal tract.1 passage
• Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer.1 passage
• Factors associated with facilitating advance care planning based on the theory of planned behaviour.1 passage
• Factors associated with health-related quality of life in patients with glioma: impact of symptoms and implications for rehabilitation.1 passage
• Factors associated with suicidal ideation in patients with multiple myeloma.1 passage
• Factors influencing the operating time for single-port laparoscopic radical nephrectomy: focus on the anatomy and distribution of the renal artery and vein.1 passage
• Factors predicting biochemical recurrence after radical prostatectomy among patients with clinical T3 prostate cancer.1 passage
• Failure pattern of elective nodal irradiation for esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy.1 passage
• Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan.1 passage
• Feasibility and safety comparison of laparoscopy-assisted versus open gastrectomy for advanced gastric carcinoma with D2 lymphadenectomy.1 passage
• Feasibility of conversion thoracoscopic esophagectomy after induction therapy for locally advanced unresectable esophageal squamous cell carcinoma.1 passage
• Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.1 passage
• Feasibility of pre-operative chemoradiotherapy with gemcitabine to treat pancreatic cancer in patients with impaired renal function.1 passage
• Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.1 passage
• Feasibility of transrectal and transperineal fiducial marker placement for prostate cancer before proton therapy.1 passage
• Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study.1 passage
• Feasibility study of cryobiopsy for practical pathological diagnosis of primary lung cancer including immunohistochemical assessment.1 passage
• Fertility-sparing surgery for early stage epithelial ovarian cancer.1 passage
• Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma.1 passage
• Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.1 passage
• Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.1 passage
• Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702).1 passage
• Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.1 passage
• First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial.1 passage
• Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.1 passage
• Forkhead box protein k1 recruits TET1 to act as a tumor suppressor and is associated with MRI detection.1 passage
• Four versus six chemotherapy cycles in endometrial carcinoma with a high risk of recurrence: a retrospective study.1 passage
• Fracture risk following stereotactic body radiotherapy for long bone metastases.1 passage
• Functional evaluation following deltoid muscle resection in patients with soft tissue sarcoma.1 passage
• Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.1 passage
• Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: a multicenter prospective Phase II trial.1 passage
• Genomic based analyses reveal unique mutational profiling and identify prognostic biomarker for overall survival in Chinese small-cell lung cancer.1 passage
• Genomic profiling of small-cell lung cancer: the era of targeted therapies.1 passage
• Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy.1 passage
• Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcome.1 passage
• Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma.1 passage
• Good death for children with cancer: a qualitative study.1 passage
• Green tea intake and colorectal cancer risk in Japan: the Takayama study.1 passage
• Gross tumor volume in sinonasal tract cancer as a predictor of local recurrence after chemoradiotherapy.1 passage
• Guideline adherence for radical cystectomy significantly affects survival outcomes in non-muscle-invasive bladder cancer patients.1 passage
• Guidelines for parenteral fluid management for terminal cancer patients.1 passage
• HAGLROS is overexpressed and promotes non-small cell lung cancer migration and invasion.1 passage
• HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy.1 passage
• Head and neck cancer in Hong Kong.1 passage
• Health-related quality of life in Japanese patients with prostate cancer following proton beam therapy: an institutional cohort study.1 passage
• Health-related quality of life in long-term survivors with Grade II gliomas: the contribution of disease recurrence and Karnofsky Performance Status.1 passage
• Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.1 passage
• High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT.1 passage
• High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrence.1 passage
• High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma.1 passage
• High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma.1 passage
• Higher serum alkaline phosphatase value indicates the need for bone mineral density testing in non-metastatic prostate cancer patients undergoing androgen deprivation therapy.1 passage
• Histologic variants associated with biological aggressiveness and poor prognosis in patients treated with radical cystectomy.1 passage
• Histopathological atlas of desmoplastic reaction characterization in colorectal cancer.1 passage
• Hospital volume and 5-year survival in head and neck cancer patients in Osaka, Japan.1 passage
• How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy?1 passage
• How to optimize the therapeutic effect of free autogenous fibula graft and wrist arthroplasty for giant cell tumors of distal radius?1 passage
• How to treat borderline resectable pancreatic cancer: current challenges and future directions.1 passage
• Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma.1 passage
• Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy.1 passage
• IMRT improves local control in patients with nasopharyngeal carcinoma compared with conventional radiotherapy: propensity score-matched analysis.1 passage
• Identification of a Japanese Lynch syndrome patient with large deletion in the 3' region of the EPCAM gene.1 passage
• Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab.1 passage
• Imaging-based definition of lower uterine segment carcinoma to improve the detection sensitivity of probable Lynch syndrome.1 passage
• Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients.1 passage
• Immune checkpoint inhibitor-related myocarditis.1 passage
• Immunochemotherapy using rituximab (RTX) and high-dose methotrexate (HD-MTX): an evaluation of the addition of RTX to HD-MTX in recurrent primary central nervous system lymphoma (PCNSL).1 passage
• Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.1 passage
• Immunomodulatory drugs in the treatment of multiple myeloma.1 passage
• Immunotherapy for advanced melanoma: current situation in Japan.1 passage
• Immunotherapy for sarcomas.1 passage
• Immunotherapy for squamous cell carcinoma of the head and neck.1 passage
• Impact of BMI for clinical outcomes in Japanese breast cancer patients.1 passage
• Impact of O6-methylguanine-DNA methyltransferase expression on the drug resistance of clear cell renal cell carcinoma.1 passage
• Impact of a prior history of cancer on prognosis after myeloablative single-unit cord blood transplantation.1 passage
• Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy.1 passage
• Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer.1 passage
• Impact of extended prostate biopsy including apical anterior region for cancer detection and prediction of surgical margin status for radical prostatectomy.1 passage
• Impact of gender and employment type on job loss among cancer survivors.1 passage
• Impact of geriatric factors on surgical and prognostic outcomes in elderly patients with soft-tissue sarcoma.1 passage
• Impact of hemoglobin levels on hemoglobin-adjusted carbon monoxide diffusion capacity after chemotherapy for testicular cancer.1 passage
• Impact of immunohistochemistry-based molecular subtype on predicting chemotherapy response and survival in patients with T1 stage bladder cancer after bladder-preserving treatment.1 passage
• Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma.1 passage
• Impact of lymph node dissection on clinical outcomes during nephroureterectomy in patients with clinically node-negative upper urinary tract urothelial cancer: subanalysis of a multi-institutional nationwide case series of the Japanese Urological Association.1 passage
• Impact of microscopic orbital periosteum invasion in orbital preservation surgery.1 passage
• Impact of minimum point dose on local control and toxicity in T3-4 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy.1 passage
• Impact of modifiable lifestyle factors on outcomes after breast cancer diagnosis: the Setouchi Breast Cancer Cohort Study.1 passage
• Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.1 passage
• Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan.1 passage
• Impact of postoperative infectious complications on adjuvant chemotherapy administration after gastrectomy for advanced gastric cancer.1 passage
• Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer.1 passage
• Impact of prophylactic percutaneous endoscopic gastrostomy tube placement on treatment tolerance in head and neck cancer patients treated with cetuximab plus radiation.1 passage
• Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3.1 passage
• Impact of reduced smoking rates on lung cancer screening programs in Japan.1 passage
• Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomes.1 passage
• Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus.1 passage
• Impact of screening colonoscopy on outcomes in colorectal cancer.1 passage
• Impact of the oncogenic status on the mode of recurrence in resected non-small cell lung cancer.1 passage
• Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.1 passage
• Implementation of cervical cancer screening and prevention in China--challenges and reality.1 passage
• Implementation status and explanatory analysis of early advance care planning for Stage IV non-small cell lung cancer patients.1 passage
• Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors.1 passage
• Improvement in pain interference after palliative radiotherapy for solid and hematologic painful tumors: a secondary analysis of a prospective observational study.1 passage
• Improvement in the prognosis of ovarian cancer in the era before addition of molecular targeting therapy.1 passage
• Improvement of the comfort perception scale in oral mucositis.1 passage
• Incidence and location of positive surgical margin among open, laparoscopic and robot-assisted radical prostatectomy in prostate cancer patients: a single institutional analysis.1 passage
• Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.1 passage
• Increased stathmin in serum as a potential tumor marker for lung adenocarcinoma.1 passage
• Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck.1 passage
• Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis.1 passage
• Influencing factors of end-of-dose failure in patients with cancer pain after oral oxycodone sustained-release tablets: a retrospective, case-control study.1 passage
• Information-seeking, information sources and ongoing support needs after discharge to prevent cancer-related lymphoedema.1 passage
• Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesothelioma.1 passage
• Initial experience of robotic anatomical segmentectomy for non-small cell lung cancer.1 passage
• Intensity modulated radiotherapy delivers competitive local control rate with limited acute toxicity in the adjuvant treatment of rectal cancer.1 passage
• Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity.1 passage
• Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204.1 passage
• Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 study.1 passage
• Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes.1 passage
• Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.1 passage
• International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers.1 passage
• Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study.1 passage
• Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer.1 passage
• Interstitial lung disease induced by alectinib (CH5424802/RO5424802).1 passage
• Intra-arterial chemoradiotherapy for head and neck cancer.1 passage
• Introducing the eighth edition of the tumor-node-metastasis classification as relevant to colorectal cancer, anal cancer and appendiceal cancer: a comparison study with the seventh edition of the tumor-node-metastasis and the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma.1 passage
• Invasive micropapillary carcinoma component is an independent prognosticator of poorer survival in Stage III colorectal cancer patients.1 passage
• Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery.1 passage
• Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.1 passage
• Is perioperative chemotherapy recommended in childhood and adolescent patients with synovial sarcoma? A systematic review.1 passage
• Is preoperative spirometry a predictive marker for postoperative complications after colorectal cancer surgery?1 passage
• Is salvage radiotherapy optimal to patients with occult cervical cancer undergoing inadvertent simple hysterectomy? A propensity score-matched analysis of a nationwide clinical oncology database.1 passage
• Is sequential free flap safe in oral cancer reconstruction in the same patient? An outcome and complication analysis.1 passage
• Is standard radical surgery necessary for elderly patients with early-stage epithelial ovarian carcinoma? ~Propensity score matched analysis~.1 passage
• Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review.1 passage
• Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.1 passage
• Issues associated with medical tourism for cancer care in Japan.1 passage
• JLCS medical practice guidelines for thymic tumors: summary of recommendations.1 passage
• JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements.1 passage
• Job resignation after cancer diagnosis among working survivors in Japan: timing, reasons and change of information needs over time.1 passage
• Joint Symposium of Korean Cancer Association & UICC-ARO-Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia.1 passage
• Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study.1 passage
• Ki-67 index of 5% could better predict the clinical prognosis of well-differentiated pancreatic neuroendocrine tumours.1 passage
• Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer.1 passage
• Kinetics differences between PSA bounce and biochemical failure in patients treated with 125I prostate brachytherapy.1 passage
• Laminin β3 expression as a prognostic factor and a predictive marker of chemoresistance in colorectal cancer.1 passage
• Landscape of education and clinical practice in geriatric oncology: a Japanese nationwide survey.1 passage
• Laparoscopic gastrointestinal anastomoses using knotless barbed absorbable sutures are safe and reproducible: a single-center experience with 242 patients.1 passage
• Laryngeal squamous cell papilloma is highly associated with human papillomavirus.1 passage
• Late-onset cystic brain necrosis after radiotherapy for nasopharyngeal carcinoma.1 passage
• Latent prostate cancer among Japanese males: a bibliometric study of autopsy reports from 1980-2016.1 passage
• Learning curve and surgical outcomes for laparoscopic surgery, including pelvic lymphadenectomy, for early stage endometrial cancer.1 passage
• Lifestyle interventions to alleviate side effects on prostate cancer patients receiving androgen deprivation therapy: a meta-analysis.1 passage
• Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review.1 passage
• Limited resection for early-stage thymoma: minimally invasive resection does not mean limited resection.1 passage
• Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results.1 passage
• Liquid-based cytology versus conventional cytology for detection of uterine cervical lesions: a prospective observational study.1 passage
• Local field radiotherapy without elective nodal irradiation for postoperative loco-regional recurrence of esophageal cancer.1 passage
• Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.1 passage
• Long non-coding RNA expression profiles reveals AK098783 is a biomarker to predict poor prognosis in patients with colorectal cancer.1 passage
• Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization.1 passage
• Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.1 passage
• Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.1 passage
• Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.1 passage
• Long-term outcomes of trans-oral robotic surgery-assisted total laryngectomy for recurrent laryngeal cancers.1 passage
• Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer.1 passage
• Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.1 passage
• Long-term survivors of primary central nervous system lymphoma.1 passage
• Long-term ureteroscopic management of upper tract urothelial carcinoma: 28-year single-centre experience.1 passage
• Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patients.1 passage
• Loss of psoas major muscle volume during systemic chemotherapy is related to worse prognosis in testicular cancer.1 passage
• Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.1 passage
• Lung adenocarcinoma in a patient with Li-Fraumeni syndrome bearing a novel germ-line mutation, TP53R333Vfs*12.1 passage
• Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.1 passage
• Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece.1 passage
• MACC1 expression is an indicator of recurrence in early-stage glottic cancer.1 passage
• MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.1 passage
• Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma.1 passage
• Malignant potential of colorectal neoplasms in Lynch syndrome: an analysis of 325 lesions endoscopically treated at a single institute.1 passage
• Management strategies to minimize mortality in liver resection for hepatocellular carcinoma.1 passage
• Marginal resection for patients with atypical lipomatous tumours of the extremities and trunk wall: a systematic review and meta-analysis.1 passage
• Medical costs of Japanese lung cancer patients during end-of-life care.1 passage
• Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosis.1 passage
• Mesenchymal-epithelial transition gene amplification and protein overexpression in stage IV pulmonary adenocarcinoma.1 passage
• Metabolic positron emission tomography parameters predict failure patterns in early non-small-cell lung cancer treated with stereotactic body radiation therapy: a single institution experience.1 passage
• Metastasis-associated protein 2 (MTA2) promotes the metastasis of non-small-cell lung cancer through the inhibition of the cell adhesion molecule Ep-CAM and E-cadherin.1 passage
• Methodological issues in observational studies and non-randomized controlled trials in oncology in the era of big data.1 passage
• MiR-30a sensitized lung cancer against neoadjuvant chemotherapy by depressing autophagy.1 passage
• MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma.1 passage
• MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.1 passage
• Mindfulness-based cognitive therapy for Japanese breast cancer patients-a feasibility study.1 passage
• Minimally invasive open surgery (MIOS) for clinical stage I lung cancer: diversity in minimally invasive procedures.1 passage
• Minimally invasive surgery for stomach cancer.1 passage
• Minimization of curative surgery for treatment of early cervical cancer: a review.1 passage
• Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.1 passage
• Modern development of high-dose-rate brachytherapy.1 passage
• Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma.1 passage
• Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma.1 passage
• Molecular-targeted therapies and precision medicine for endometrial cancer.1 passage
• Mucositis with anti-EGFR monoclonal antibody in cancer patients: a meta-analysis of randomized controlled trials.1 passage
• Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in Japan.1 passage
• Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6).1 passage
• Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group.1 passage
• Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study.1 passage
• Myoepithelioma occurring in the posterior mediastinum harboring EWSR1 rearrangement: a case report.1 passage
• NCCN Asia Consensus Statement prostate cancer.1 passage
• NLRP7 and KHDC3L variants in Chinese patients with recurrent hydatidiform moles.1 passage
• National incidence and initial therapy for thymic carcinoma in Japan: based on analysis of hospital-based cancer registry data, 2009-2015.1 passage
• National survey of radiation oncologists' practice patterns regarding hormone-naïve prostate cancer with bone metastases.1 passage
• Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).1 passage
• Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer.1 passage
• Neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer: multicenter retrospective study.1 passage
• Neoadjuvant therapy and risk of bronchopleural fistula after lung cancer surgery: a systematic meta-analysis of 14 912 patients.1 passage
• Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.1 passage
• Neuroblastoma.1 passage
• New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.1 passage
• New classification of hydronephrosis on 18F-FDG-PET/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma.1 passage
• New developments in systemic therapy for advanced biliary tract cancer.1 passage
• New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer.1 passage
• New simple radiological criteria proposed for multiple primary lung cancers.1 passage
• Nidogen-1: a candidate biomarker for ovarian serous cancer.1 passage
• Nine cases of carcinoma with neuroendocrine features in the head and neck: clinicopathological characteristics and clinical outcomes.1 passage
• Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancer.1 passage
• Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.1 passage
• Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study.1 passage
• Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study.1 passage
• Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.1 passage
• Nivolumab-induced organizing pneumonia in a melanoma patient.1 passage
• Nivolumab-induced thyroid dysfunction.1 passage
• No clinical significance of the time interval between biopsy and robotic-assisted radical prostatectomy for patients with clinically localized prostate cancer on biochemical recurrence: a propensity score matching analysis.1 passage
• Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.1 passage
• Non-linear association between long-term outcome and preoperative neutrophil-to-lymphocyte ratio in patients undergoing curative resection for gastric cancer: a retrospective analysis of 1335 cases in a tetrachotomous manner.1 passage
• Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).1 passage
• Novel hybrid endoscopy-assisted larynx-preserving esophagectomy for cervical esophageal cancer (with video).1 passage
• Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.1 passage
• Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1).1 passage
• Obesity is correlated with poor outcome after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia.1 passage
• Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial.1 passage
• Oestrogen receptor alpha in papillary thyroid carcinoma: association with clinical features and BRAFV600E mutation.1 passage
• Omitting surgery for early breast cancer showing clinical complete response to primary systemic therapy.1 passage
• Onco-nephrology: current concepts and future perspectives.1 passage
• Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.1 passage
• Oncological and peri-surgical outcomes of radical prostatectomy for non-metastatic prostate cancer with prostate-specific antigen level of 50 ng/ml or greater.1 passage
• Oncological and prognostic analysis of soft tissue sarcoma of the elbow: report using the bone and soft tissue tumor registry in Japan.1 passage
• Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.1 passage
• Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives.1 passage
• One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control?1 passage
• Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer.1 passage
• Optimal adjuvant radiotherapy dose for stage I, II or III Merkel cell carcinoma: an analysis of the National Cancer Database.1 passage
• Optimal plasma pretreatment EBV DNA cut-off point for nasopharyngeal cancer patients treated with intensity modulated radiation therapy.1 passage
• Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.1 passage
• Optimism, pessimism and self-efficacy in female cancer patients.1 passage
• Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status.1 passage
• Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.1 passage
• Osteoporosis is less frequent in endometrial cancer survivors with hypertriglyceridemia.1 passage
• Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan.1 passage
• Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma.1 passage
• Outcomes after thoracoscopic surgery in octogenarian patients with clinical N0 non-small-cell lung cancer.1 passage
• Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.1 passage
• Outcomes of active surveillance of clinical stage I non-seminomatous germ cell tumors: sub-analysis of the multi-institutional nationwide case series of the Japanese Urological Association.1 passage
• Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study.1 passage
• Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*.1 passage
• Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy.1 passage
• Overexpression of Janus kinase 2 protein in extramammary Paget's disease.1 passage
• Overview of current and future systemic therapy for metastatic renal cell carcinoma.1 passage
• PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy.1 passage
• PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer.1 passage
• PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established patient-derived cell panel assay.1 passage
• Palliative brachytherapy and external beam radiotherapy for dysphagia from esophageal cancer: a nationwide survey in Japan.1 passage
• Palliative care physicians' perspectives of management for terminally ill cancer patients with death rattle: a nationwide survey.1 passage
• Palliative pain relief and safety of percutaneous radiofrequency ablation combined with cement injection for bone metastasis.1 passage
• Palliative radiotherapy for breast cancer patients with skin invasion: a multi-institutional prospective observational study.1 passage
• Participation of Korean families at high risk for hereditary breast and ovarian cancer in BRCA1/2 genetic testing.1 passage
• Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry.1 passage
• Pathologically examining a minimum of three lymph nodes could better determine node negativity in patients with non-metastatic chromophobe renal cell carcinoma.1 passage
• Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy.1 passage
• Patient perceptions of curability and physician-reported disclosures of incurability in Japanese patients with unresectable/recurrent cancer: a cross-sectional survey.1 passage
• Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.1 passage
• Patient-reported outcomes after open radical prostatectomy, laparoscopic radical prostatectomy and permanent prostate brachytherapy.1 passage
• Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.1 passage
• Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer.1 passage
• Patterns of immune infiltration in gastric cancer and their clinical significance.1 passage
• Patterns of radiotherapy infrastructure in Japan and in other countries with well-developed radiotherapy infrastructures.1 passage
• Pemetrexed-related interstitial lung disease reported from post marketing surveillance (malignant pleural mesothelioma/non-small cell lung cancer).1 passage
• Perceived social support and its impact on depression and health-related quality of life: a comparison between cancer patients and general population.1 passage
• Perceptions of children and their parents about the pain experienced during their hospitalization and its impact on parents' quality of life.1 passage
• Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.1 passage
• Perioperative change in neutrophil-lymphocyte ratio predicts the overall survival of patients with bladder cancer undergoing radical cystectomy.1 passage
• Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).1 passage
• Perioperative morbidity and mortality of octogenarians treated by radical cystectomy-a multi-institutional retrospective study in Japan.1 passage
• Perioperative therapies for urological cancers.1 passage
• Perioperative treatments for stage IB-IIB uterine cervical cancer.1 passage
• Personality traits and coping styles explain anxiety in lung cancer patients to a greater extent than other factors.1 passage
• Perspectives on follow-up care and research for childhood cancer survivors: results from an international SIOP meet-the-expert questionnaire in Kyoto, 2018.1 passage
• Perspectives on research activity in the USA on Cancer Precision Medicine.1 passage
• Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study.1 passage
• Pharmacokinetics of initial full and subsequent reduced doses of S-1 in patients with locally advanced head and neck cancer-effect of renal insufficiency.1 passage
• Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives.1 passage
• Phase 1 study of ombrabulin in combination with cisplatin (CDDP) in Japanese patients with advanced solid tumors.1 passage
• Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors.1 passage
• Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia.1 passage
• Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma.1 passage
• Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.1 passage
• Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer.1 passage
• Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.1 passage
• Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea.1 passage
• Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors.1 passage
• Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer.1 passage
• Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).1 passage
• Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer.1 passage
• Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer.1 passage
• Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer.1 passage
• Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).1 passage
• Phase II trial of neoadjuvant chemotherapy with S-1 and oxaliplatin plus bevacizumab for colorectal liver metastasis (N-SOG 05 trial).1 passage
• Phase II/III study in children and adolescents with newly diagnosed B-cell precursor acute lymphoblastic leukemia: protocol for a nationwide multicenter trial in Japan.1 passage
• Phase III study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in pediatric patients.1 passage
• Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE).1 passage
• Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study).1 passage
• Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).1 passage
• Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial).1 passage
• Plasma ghrelin levels as a predictor of adverse renal events due to cisplatin-based chemotherapy in patients with esophageal cancer.1 passage
• Platinum hypersensitivity and desensitization.1 passage
• Population-based cohort study assessing the efficacy of cervical cytology (Pap smear) and human papillomavirus (HPV) testing as modalities for cervical cancer screening.1 passage
• Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?1 passage
• Possibilities for and limits of upfront surgical strategy with lateral pelvic node dissection for low rectal cancer.1 passage
• Post hoc analysis of Japanese patients from the placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer-updated results.1 passage
• Post transplant cyclophosphamide based haplo-identical transplant versus umbilical cord blood transplant; a meta-analysis.1 passage
• Post-crisis efforts towards recovery and resilience after the Fukushima Daiichi Nuclear Power Plant accident.1 passage
• Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.1 passage
• Post-marketing surveillance study of trifluridine/tipiracil in patients with metastatic colorectal cancer.1 passage
• Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity.1 passage
• Postmarketing observational study of pazopanib in patients with metastatic soft tissue sarcoma in Japan.1 passage
• Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysis.1 passage
• Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy achieved the equivalent survival compared with concurrent chemoradiotherapy in cervical cancer patients with intermediate-risk.1 passage
• Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study.1 passage
• Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.1 passage
• Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.1 passage
• Practice patterns of surgery for advanced ovarian cancer: analysis from international surveys.1 passage
• Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.1 passage
• Prediction model of critical weight loss in cancer patients during particle therapy.1 passage
• Prediction of acute gastrointestinal and genitourinary radiation toxicity in prostate cancer patients using lymphocyte microRNA.1 passage
• Prediction of metastasis to mesorectal, internal iliac and obturator lymph nodes according to size criteria in patients with locally advanced lower rectal cancer.1 passage
• Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.1 passage
• Predictive ability of prognostic nutritional index in surgically resected gastrointestinal stromal tumors: a propensity score matching analysis.1 passage
• Predictive factors for survival and correlation to toxicity in advanced Stage III non-small cell lung cancer patients with concurrent chemoradiation.1 passage
• Predictive factors of gastroduodenal bleeding after postoperative radiotherapy in biliary tract cancer.1 passage
• Predictive factors of late biochemical recurrence after radical prostatectomy.1 passage
• Predictive value of cadherin-11 for subsequent recurrence and progression in non-muscle invasive bladder cancer.1 passage
• Predictive value of genetic analysis for pathological complete response to preoperative treatment in HER2 positive, HR negative early breast cancer (PASSION trial).1 passage
• Predictive value of radiological response rate for pathological response to neoadjuvant chemotherapy and post-cystectomy survival of bladder urothelial cancer.1 passage
• Predictors of poor response to secondary alternative antiandrogen therapy with flutamide in metastatic castration-resistant prostate cancer.1 passage
• Predictors of venous thromboembolism development before and during chemotherapy for advanced germ cell tumor.1 passage
• Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.1 passage
• Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212).1 passage
• Preoperative chemoradiotherapy for elderly patients with locally advanced rectal cancer-a real-world outcome study.1 passage
• Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study.1 passage
• Preoperative fall risk assessment score as a prognostic factor in gastric cancer patients after gastrectomy.1 passage
• Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection.1 passage
• Preoperative prognostic nutritional index as a method to predict postoperative complications after major head and neck surgery with free tissue transfer reconstruction.1 passage
• Preoperative prognostic nutritional index as a predictor of outcomes in elderly patients after surgery for lung cancer.1 passage
• Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical resection.1 passage
• Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma.1 passage
• Present status of support for adolescent and young adult cancer patients in member hospitals of Japanese Association of Clinical Cancer Centers.1 passage
• Preservation of fertility in patients with hematological malignancies.1 passage
• Prevalence and associated factors of perceived cancer-related stigma in Japanese cancer survivors.1 passage
• Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.1 passage
• Prevalence and clinicopathological/molecular characteristics of mismatch repair protein-deficient tumours among surgically treated patients with prostate cancer in a Japanese hospital-based population.1 passage
• Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population.1 passage
• Prevalence and molecular characteristics of DNA mismatch repair protein-deficient sebaceous neoplasms and keratoacanthomas in a Japanese hospital-based population.1 passage
• Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population.1 passage
• Prevalence and predictive factors of depression and anxiety in patients with pancreatic cancer: a longitudinal study.1 passage
• Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.1 passage
• Prevalence of Lynch syndrome and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population.1 passage
• Prevalence, course and factors associated with delirium in elderly patients with advanced cancer: a longitudinal observational study.1 passage
• Prevention of IVR: a need for investigation.1 passage
• Prevention of infection-related cancers in the WHO Western Pacific Region.1 passage
• Primary capicua transcriptional repressor-rearranged sarcoma of the lung.1 passage
• Primary tumour ulceration in cutaneous melanoma: its role on TNM stages.1 passage
• Problems, goals and solutions reported by cancer patients participating in group problem-solving therapy.1 passage
• Prognosis and surgical outcome of soft tissue sarcoma with malignant fungating wounds.1 passage
• Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors.1 passage
• Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis.1 passage
• Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.1 passage
• Prognostic accuracy of different lymph node staging systems in rectal adenocarcinoma with or without preoperative radiation therapy.1 passage
• Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.1 passage
• Prognostic factors for patients with brain metastasis from gynecological cancer: a significance of treatment-free interval of more than 6 months.1 passage
• Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy.1 passage
• Prognostic factors of non-ampullary duodenal adenocarcinoma.1 passage
• Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.1 passage
• Prognostic impact of bulky swollen lymph nodes in cN1 non-small cell lung cancer patients.1 passage
• Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).1 passage
• Prognostic impact of incisional or excisional biopsy of cervical lymph node metastases of solid tumors.1 passage
• Prognostic impact of local radiotherapy on metastatic urothelial carcinoma patients receiving systemic chemotherapy.1 passage
• Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.1 passage
• Prognostic impact of prior local therapy in castration-resistant prostate cancer.1 passage
• Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer.1 passage
• Prognostic impact of systemic therapy change in metastatic renal cell carcinoma treated with cytoreductive nephrectomy.1 passage
• Prognostic impact of the number of lateral pelvic lymph node metastases on rectal cancer.1 passage
• Prognostic implications of diffusion-weighted magnetic resonance imaging in patients with superior sulcus tumors receiving induction chemoradiation therapy.1 passage
• Prognostic importance of pathological response to neoadjuvant chemotherapy followed by definitive surgery in advanced oral squamous cell carcinoma.1 passage
• Prognostic importance of ultrasound BI-RADS classification in breast cancer patients.1 passage
• Prognostic index score predicts outcome of patients with Stage I non-small cell lung cancer after stereotactic body radiation therapy.1 passage
• Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer.1 passage
• Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.1 passage
• Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer.1 passage
• Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.1 passage
• Prognostic significance of neutrophil-to-lymphocyte ratio in collecting duct carcinoma.1 passage
• Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan.1 passage
• Prognostic significance of surgical extranodal extension in head and neck squamous cell carcinoma patients.1 passage
• Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.1 passage
• Prognostic significance of the controlling nutritional status score in patients with metastatic renal cell carcinoma diagnosed before an era of first-line immune-oncology combination therapies.1 passage
• Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.1 passage
• Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma.1 passage
• Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.1 passage
• Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis.1 passage
• Prognostic value of EUS combined with MSCT in predicting the recurrence and metastasis of patients with gastric cancer.1 passage
• Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis.1 passage
• Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study.1 passage
• Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.1 passage
• Prognostic value of p16 expression irrespective of human papillomavirus status in patients with oropharyngeal carcinoma.1 passage
• Prognostic value of psoas major muscle density in patients with breast cancer metastases to bone: a retrospective single-center cohort study.1 passage
• Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma.1 passage
• Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.1 passage
• Progress and controversy for the role of chemotherapy in nasopharyngeal carcinoma.1 passage
• Progress of liver resection for hepatocellular carcinoma in Taiwan.1 passage
• Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications.1 passage
• Prophylactic donor lymphocyte infusion for relapse prevention: a meta-analysis.1 passage
• Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN study.1 passage
• Prospective evaluation of sentinel node navigation surgery in Japanese patients with low-risk endometrial cancer-safety and occurrence of lymphedema.1 passage
• Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: a single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study).1 passage
• Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis.1 passage
• Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A).1 passage
• Prospective observational study of the efficacy of nivolumab in Japanese patients with advanced melanoma (CREATIVE study).1 passage
• Prospective randomized investigation implementing immunonutritional therapy using a nutritional supplement with a high blend ratio of ω-3 fatty acids during the perioperative period for head and neck carcinomas.1 passage
• Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma.1 passage
• Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.1 passage
• Prostate-specific antigen response patterns during cabazitaxel therapy in patients with metastatic castration-resistant prostate cancer.1 passage
• Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer.1 passage
• Proteasome inhibitors for multiple myeloma.1 passage
• Proton beam therapy in Japan: current and future status.1 passage
• Providing written information increases patient satisfaction: a web-based questionnaire survey of Japanese cancer survivors.1 passage
• Psychological burden on patients with cancer of unknown primary: from onset of symptoms to initial treatment.1 passage
• Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study.1 passage
• Publication of lung cancer clinical trials in the Japanese Clinical Trial Registry.1 passage
• Pull-through resection without free-flap reconstruction for lateral wall oropharyngeal cancer.1 passage
• Pulmonary metastasis from giant cell tumor of bone: clinical outcome prior to the introduction of molecular target therapy.1 passage
• Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review.1 passage
• Quality assurance for a multicenter Phase II study of stereotactic ablative radiotherapy for hepatocellular carcinoma ≤5 cm: a planning dummy run.1 passage
• Quality assurance manual of endoscopic screening for gastric cancer in Japanese communities.1 passage
• Quality of life and functional status of terminally ill head and neck cancer patients: a nation-wide, prospective observational study at tertiary cancer centers in Japan.1 passage
• Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: a multicenter study in Taiwan.1 passage
• Quality of reporting of chemotherapy compliance in randomized controlled trials of breast cancer treatment.1 passage
• Quantification of the increase in thyroid cancer prevalence in Fukushima after the nuclear disaster in 2011--a potential overdiagnosis?1 passage
• Radiation oncology in Canada.1 passage
• Radiation-induced dermatitis after administration of mogamulizumab for adult T-cell leukaemia/lymphoma: a multi-institutional retrospective study.1 passage
• Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.1 passage
• Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.1 passage
• Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection-can local recurrence be radically cured by radiation?1 passage
• Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT).1 passage
• Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC).1 passage
• Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†.1 passage
• Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701.1 passage
• Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.1 passage
• Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).1 passage
• Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND).1 passage
• Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).1 passage
• Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD).1 passage
• Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.1 passage
• Rapid on-site evaluation of touch imprints of biopsies improves the diagnostic yield of transbronchial biopsy for endoscopically nonvisible malignancy: a retrospective study.1 passage
• Rare cancers in Japan: definition, clinical features and future perspectives.1 passage
• Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan.1 passage
• Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients.1 passage
• Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study.1 passage
• Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer.1 passage
• Recent advances in Hodgkin lymphoma: interim PET and molecular-targeted therapy.1 passage
• Recent advances in molecular targeted therapy for unresectable and metastatic BRAF-mutated melanoma.1 passage
• Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.1 passage
• Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012-2015 hospital-based cancer registry data.1 passage
• Recent progress and future direction of cancer epidemiological research in Japan.1 passage
• Recovery from anemia and leukocytopenia after abstinence in Japanese alcoholic men and their genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2.1 passage
• Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemia.1 passage
• Regional colorectal cancer screening program using colonoscopy on an island: a prospective Nii-jima study.1 passage
• Regulatory changes after the enforcement of the new Clinical Trials Act in Japan.1 passage
• Relationship between anastomotic leakage and CT value of the mesorectum in laparoscopic anterior resection for rectal cancer.1 passage
• Relationship between smoking and multiple colorectal cancers in patients with Japanese Lynch syndrome: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.1 passage
• Relationship of tumor PD-L1 expression with EGFR wild-type status and poor prognosis in lung adenocarcinoma.1 passage
• Reliability and validity of a Japanese version of the psychosocial assessment tool for families of children with cancer.1 passage
• Renal function and urological complications after radical hysterectomy with postoperative radiotherapy and platinum-based chemotherapy for cervical cancer.1 passage
• Repeat biopsy of primary disease negatively affects the outcome of patients with nasopharyngeal cancer treated with definitive intensity-modified radiotherapy: a cohort analysis of 795 patients.1 passage
• Report of the forth Asian Prostate Cancer (A-CaP) study meeting.1 passage
• Repression of the expression of PPP3CC by ZEB1 confers activation of NF-κB and contributes to invasion and growth in glioma cells.1 passage
• Research policy in supportive care and palliative care for cancer dyspnea.1 passage
• Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosis.1 passage
• Respiration-gated fast-rescanning carbon-ion radiotherapy.1 passage
• Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators.1 passage
• Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer.1 passage
• Retrospective analysis of definitive radiotherapy for neck node metastasis from unknown primary tumor: Japanese Radiation Oncology Study Group study.1 passage
• Retrospective analysis of survival in patients with leptomeningeal carcinomatosis from lung adenocarcinoma treated with erlotinib and gefitinib.1 passage
• Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer.1 passage
• Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.1 passage
• Retrospective observational study of occult cervical lymph-node metastasis in T1N0 tongue cancer.1 passage
• Review of the diagnosis and treatment of brain metastases.1 passage
• Revised staging system for malignant lymphoma based on the Lugano classification.1 passage
• Risk and prognostic factors for multiple primary carcinomas in patients with head and neck cancer.1 passage
• Risk factor for wound complications following wide resection of soft tissue sarcoma in the adductor compartment of the thigh.1 passage
• Risk factors for acute exacerbation of idiopathic interstitial pneumonia in patients undergoing lung cancer treatment.1 passage
• Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome.1 passage
• Risk factors for lymphatic complications following lymphadenectomy in patients with cervical cancer.1 passage
• Risk factors for metastasis to No.14v lymph node and prognostic value of 14v status for gastric cancer patients after surgery.1 passage
• Risk factors for postoperative delirium in patients undergoing major head and neck cancer surgery: a meta-analysis.1 passage
• Risk factors of post-operative pneumonia in elderly patients with gastric cancer: a retrospective cohort study.1 passage
• Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy.1 passage
• Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong.1 passage
• Role of multimodality therapy in cIIIA-N2 non-small cell lung cancer: perspective.1 passage
• Role of surgery in N2 NSCLC: pros.1 passage
• Role of surgery in clinical N2 non-small-cell lung cancer: a pro and con debate; the 'con' viewpoint.1 passage
• Role sharing between minimally invasive oesophagectomy and organ preservation approach for surgically resectable advanced oesophageal cancer.1 passage
• Roles of volunteers and professionals in medical development -- insights from the development of Allo-HSCT.1 passage
• Safety and discomfort during bronchoscopy performed under sedation with fentanyl and midazolam: a prospective study.1 passage
• Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study.1 passage
• Safety and efficacy of abiraterone acetate plus prednisolone in patients with castration-resistant prostate cancer: a prospective, observational, post-marketing surveillance study.1 passage
• Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study.1 passage
• Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.1 passage
• Safety and efficacy of mucosal immunotherapy using human papillomavirus (HPV) type 16 E7-expressing Lactobacillus-based vaccine for the treatment of high-grade squamous intraepithelial lesion (HSIL): the study protocol of a randomized placebo-controlled clinical trial (MILACLE study).1 passage
• Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study.1 passage
• Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study.1 passage
• Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer.1 passage
• Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.1 passage
• Safety of central compartment neck dissection for transoral endoscopic thyroid surgery in papillary thyroid carcinoma.1 passage
• Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia.1 passage
• Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor.1 passage
• Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study.1 passage
• Salvage radiation therapy for prostate cancer patients after prostatectomy.1 passage
• Salvage surgery for small cell lung cancer after chemoradiotherapy.1 passage
• Sarcopenia and obesity in long-term survivors of childhood leukemia/lymphoma: a report from a single institution.1 passage
• Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer.1 passage
• Screening for untreated depression in cancer patients: a Japanese experience.1 passage
• Screening of chronic radiation proctitis and colorectal cancer using periodic total colonoscopy after external beam radiation therapy for prostate cancer.1 passage
• Screening using the fifth vital sign in the electronic medical recording system.1 passage
• Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery.1 passage
• Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A.1 passage
• Second primary osteosarcomas in patients with retinoblastoma.1 passage
• Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis.1 passage
• Secondary bone/soft tissue sarcoma in childhood cancer survivors: a nationwide hospital-based case-series study in Japan.1 passage
• Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies.1 passage
• Selective neck irradiation for supraglottic cancer: focus on Sublevel IIb omission.1 passage
• Sentinel lymph node biopsy may be unnecessary for ductal carcinoma in situ of the breast that is small and diagnosed by preoperative biopsy.1 passage
• Sentinel node navigation surgery in cervical and endometrial cancer: a review.1 passage
• Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients.1 passage
• Serum levels of testosterone and SHBG in association with body mass index improve the predictive capability of consolidate tumor biomarkers in pre- and postmenopausal breast cancer patients.1 passage
• Serum microRNA expression profile as a diagnostic panel for gastric cancer.1 passage
• Severe esophagitis associated with cytomegalovirus during concurrent chemoradiotherapy for esophageal cancer.1 passage
• Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab.1 passage
• Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.1 passage
• Severity of emphysema as a prognosticator of resected early lung cancer: an analysis classified by Goddard score.1 passage
• Sex differences in lung cancer survival: long-term trends using population-based cancer registry data in Osaka, Japan.1 passage
• Sex- and age-related differences in the distribution of bladder cancer metastases.1 passage
• Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients [Izmir Oncology Group (IZOG) study].1 passage
• Sharing genetic test results of germline pathogenic variants of hereditary cancer with relatives: A single-center cross-sectional study.1 passage
• Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer.1 passage
• Short-term safety of adjuvant chemoradiotherapy after local resection for patients with high-risk submucosal invasive rectal cancer: a single-arm, multicenter phase II trial.1 passage
• Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer.1 passage
• Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.1 passage
• Significance of primary lesion resection in Stage IV breast cancer.1 passage
• Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer.1 passage
• Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.1 passage
• Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).1 passage
• Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).1 passage
• Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.1 passage
• Skeletal muscle measurements predict surgical wound complications but not overall survival in patients with soft tissue sarcoma.1 passage
• Skin problems and EGFR-tyrosine kinase inhibitor.1 passage
• Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.1 passage
• Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study.1 passage
• Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomy.1 passage
• Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer.1 passage
• Soft tissue sarcoma in adolescent and young adult patients: a retrospective study using a nationwide bone and soft tissue tumor registry in Japan.1 passage
• Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis.1 passage
• Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.1 passage
• Spontaneous regression of colon cancer.1 passage
• Stage III disease of ovarian, tubal and peritoneal cancers can be accurately diagnosed with pre-operative CT. Japan Clinical Oncology Group Study JCOG0602.1 passage
• Statistical inference for estimating the incidence of cancer at the prefectural level in Japan.1 passage
• Stereotactic body radiation therapy for Japanese patients with localized prostate cancer: 2-year results and predictive factors for acute genitourinary toxicities.1 passage
• Stereotactic body radiotherapy (SBRT) for Stage I lung cancer.1 passage
• Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer.1 passage
• Stereotactic body radiotherapy for second pulmonary nodules after operation for an initial lung cancer.1 passage
• Stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer: Does beam-on time matter?1 passage
• Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A).1 passage
• Sterilized talc pleurodesis for malignant pleural effusions: a Phase II study for investigational new drug application in Japan.1 passage
• Study on the prevention of infection in terminal cancer patients applying epidural analgesia by adding cefazolin to anesthetics: a randomized controlled trial.1 passage
• Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report.1 passage
• Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy.1 passage
• Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients.1 passage
• Study protocol for an International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer (T-REX study).1 passage
• Study risk assessment of Japan Clinical Oncology Group (JCOG) clinical trials using the European Organisation for Research and Treatment of Cancer (EORTC) study risk calculator.1 passage
• Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy.1 passage
• Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy.1 passage
• Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).1 passage
• Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.1 passage
• Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE).1 passage
• Successful desensitization protocol for hypersensitivity reaction probably caused by dabrafenib in a patient with metastatic melanoma.1 passage
• Successful treatment of metastatic rhabdomyosarcoma with radiochemotherapy and allogeneic hematopoietic stem cell transplantation.1 passage
• Suicide in patients with gastric cancer: a population-based study.1 passage
• Sunitinib versus sorafenib for patients with advanced renal cell carcinoma with renal impairment before the immune-oncology therapy era.1 passage
• Superselective intra-arterial chemotherapy with concurrent radiotherapy for advanced parotid squamous cell carcinoma: a case report.1 passage
• Supportive care needs and psychological distress and/or quality of life in ambulatory advanced colorectal cancer patients receiving chemotherapy: a cross-sectional study.1 passage
• Surgery and imatinib therapy for liver oligometastasis of GIST: a study of Japanese Study Group on GIST.1 passage
• Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer.1 passage
• Surgical intervention for ground glass dominant lesions: observation or outright resection?1 passage
• Surgical management around the paratracheal area of hypopharyngeal cancer.1 passage
• Surgical outcomes of bone sarcoma of the foot.1 passage
• Surgical outcomes of primary lung cancers following esophagectomy for primary esophageal carcinoma.1 passage
• Surgical outcomes of robot-assisted rectal cancer surgery using the da Vinci Surgical System: a multi-center pilot Phase II study.1 passage
• Surgical resection for clinical-Stage I radiological pure-solid lung cancer that met the current high risk criteria.1 passage
• Surgical resection of the primary lesion for osteosarcoma patients with metastasis at initial diagnosis.1 passage
• Surgical upstaging rates in patients meeting the eligibility for active surveillance trials.1 passage
• Surgical-related risk factors associated with anastomotic leakage after resection for rectal cancer: a meta-analysis.1 passage
• Surveillance of patients with stage I or II colorectal cancer in Japan: a JCOG study group questionnaire survey.1 passage
• Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the world.1 passage
• Survival and prognostic association in stage IV colorectal cancer patients treated with chemotherapy in Bangladesh.1 passage
• Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3.1 passage
• Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.1 passage
• Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.1 passage
• Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.1 passage
• Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.1 passage
• Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective study.1 passage
• Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study.1 passage
• Synchronous dilemma of sarcoid-like reaction and drastic response after PD-1 blockade administration in lung cancer.1 passage
• Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies.1 passage
• Systematic regional lymph node dissection for upper tract urothelial carcinoma improves patient survival.1 passage
• Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer.1 passage
• Systemic therapy for hepatocellular carcinoma: current status and future perspectives.1 passage
• Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy.1 passage
• TNM classification of gynaecological malignant tumours, eighth edition: changes between the seventh and eighth editions.1 passage
• TNM classification of malignant tumors (Breast Cancer Study Group).1 passage
• Temozolomide and etoposide combination for the treatment of relapsed osteosarcoma.1 passage
• Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.1 passage
• The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.1 passage
• The Charlson comorbidity index is a prognostic factor in sinonasal tract squamous cell carcinoma.1 passage
• The Japanese Guidelines for Breast Cancer Screening.1 passage
• The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: past activities, current status and future direction.1 passage
• The association between overweight, obesity and ovarian cancer: a meta-analysis.1 passage
• The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.1 passage
• The clinical presentation and favorable prognosis of patients with isolated metachronous brain metastasis from germ cell tumors.1 passage
• The combination of histone deacetylase and p53 expressions and histological subtype has prognostic implication in uterine leiomyosarcoma.1 passage
• The current clinical use of adjuvant analgesics for refractory cancer pain in Japan: a nationwide cross-sectional survey.1 passage
• The current state of immunotherapy for primary and secondary brain tumors: similarities and differences.1 passage
• The current state of stomach cancer surgery in the world.1 passage
• The current status of inpatient cancer rehabilitation provided by designated cancer hospitals in Japan.1 passage
• The dawn of robotic surgery in otolaryngology-head and neck surgery.1 passage
• The diagnostic value of histology and cytology samples during endobronchial ultrasound with a guide sheath.1 passage
• The distress and benefit to bereaved family members of participating in a post-bereavement survey.1 passage
• The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer.1 passage
• The effect of escalating the boost dose for patients with involved resection margin after breast-conserving surgery.1 passage
• The effect of lymphadenectomy on survival and recurrence in patients with ovarian cancer: a systematic review and meta-analysis.1 passage
• The effect of predisposing atheroembolic risk factors on renal functional recovery between laparoscopy and open technique in patients with T1-stage renal cell carcinoma who underwent partial nephrectomy: a retrospective comparison study.1 passage
• The effectiveness of proton beam therapy for liver metastatic recurrence in gastric cancer patients.1 passage
• The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial.1 passage
• The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.1 passage
• The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.1 passage
• The first case report of polymerase proofreading-associated polyposis in POLD1 variant, c.1433G>A p.S478N, in Japan.1 passage
• The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer.1 passage
• The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.1 passage
• The impact of pain control on physical and psychiatric functions of cancer patients: a nation-wide survey in Taiwan.1 passage
• The impact of young age on the prognosis for colorectal cancer: a population-based study in Taiwan.1 passage
• The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma.1 passage
• The influence of coping types on post-traumatic growth in patients with primary breast cancer.1 passage
• The influence of dynamic changes in lipid metabolism on survival outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors.1 passage
• The investigation study using a questionnaire about the employment of Japanese breast cancer patients.1 passage
• The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma.1 passage
• The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients.1 passage
• The outcomes of reconstruction using frozen autograft combined with iodine-coated implants for malignant bone tumors: compared with non-coated implants.1 passage
• The possibility of clinical sequencing in the management of cancer.1 passage
• The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.1 passage
• The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis.1 passage
• The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer.1 passage
• The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer.1 passage
• The prognostic signature of the somatic mutations in Ewing sarcoma: from a network view.1 passage
• The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy.1 passage
• The role of elective neck dissection for cT4aN0 glottic squamous cell carcinoma.1 passage
• The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer.1 passage
• The role of prophylactic cranial irradiation for patients with small-cell lung cancer.1 passage
• The role of pulmonary resection in tumors metastatic from esophageal carcinoma.1 passage
• The role of radiotherapy in the age of immunotherapy.1 passage
• The safety and effect of chemotherapy with short hydration for urothelial cancer on patients' quality of life.1 passage
• The safety and effectiveness of carbon nanoparticles suspension in tracking lymph node metastases of colorectal cancer: a prospective randomized controlled trial.1 passage
• The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.1 passage
• The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study.1 passage
• The significance of biopsy scar excision at the time of skin- or nipple-sparing mastectomy with immediate breast reconstruction.1 passage
• The silent mutation MLH1 c.543C>T resulting in aberrant splicing can cause Lynch syndrome: a case report.1 passage
• The single-base-pair deletion, MSH2 c.2635-3delC affecting intron 15 splicing can be a cause of Lynch syndrome.1 passage
• The status quo of treatment and clinical outcomes for patients over 80 years of age with high-grade soft tissue sarcoma: report from the soft tissue tumor registry in Japan.1 passage
• The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer.1 passage
• The updated points of TNM classification of urological cancers in the 8th edition of AJCC and UICC.1 passage
• The use of bevacizumab is correlated with improved post-progression survival in advanced recurrent ovarian cancer.1 passage
• The use of psychosocial support services among Japanese breast cancer survivors.1 passage
• The utility of EBUS-TBNA in the diagnosis of suspected intrathoracic recurrence after esophageal cancer surgery.1 passage
• The validity and reliability of the Korean version of the Cancer-chemotherapy Concerns Rating Scale.1 passage
• Therapeutic antibodies for multiple myeloma.1 passage
• Therapeutic approaches for patients with coexisting familial adenomatous polyposis and colorectal cancer.1 passage
• Therapeutic benefit of lymphadenectomy for older patients with urothelial carcinoma of the upper urinary tract: a propensity score matching study.1 passage
• Thymic epithelial tumor treatment in Japan: analysis of hospital cancer registry and insurance claims data, 2012-2014.1 passage
• Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma.1 passage
• Transarterial management of advance lung cancer.1 passage
• Transferrin predicts outcome in patients who underwent liver resection for colorectal liver metastases.1 passage
• Transformation to small-cell lung cancer as a mechanism of acquired resistance to crizotinib and alectinib.1 passage
• Translation, validation of the EORTC esophageal cancer quality-of-life questionnaire for Japanese with esophageal squamous cell carcinoma: analysis in thoraco-laparoscopic esophagectomy versus open esophagectomy.1 passage
• Transurethral resection of the prostate for patients with Gleason score 6 prostate cancer and symptomatic prostatic enlargement: a risk-adaptive strategy for the era of active surveillance.1 passage
• Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?1 passage
• Treatment of locally advanced prostate cancer (Stage T3).1 passage
• Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.1 passage
• Treatment outcomes of erlotinib plus gemcitabine as late-line chemotherapy in unresectable pancreatic cancer.1 passage
• Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma.1 passage
• Treatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery.1 passage
• Treatment patterns and outcomes of unresectable pancreatic cancer patients in real-life practice: a region-wide analysis.1 passage
• Treatment patterns in pancreatic cancer patients based on a hospital claims database in Japan.1 passage
• Treatment possibilities of ipilimumab-induced thrombocytopenia--case study and literature review.1 passage
• Treatment results of 99 patients undergoing open partial hypopharyngectomy with larynx preservation.1 passage
• Treatment results of adjuvant pelvic radiotherapy after radical hysterectomy for low-risk Stage IB1-IIA cervical cancer.1 passage
• Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings.1 passage
• Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection.1 passage
• Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.1 passage
• Trends and projections of cancer mortality in Osaka, Japan from 1977 to 2032.1 passage
• Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.1 passage
• Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003-13.1 passage
• Trousseau's syndrome: cancer-associated thrombosis.1 passage
• Tumor bleeding requiring intervention and the correlation with anemia in uterine cervical cancer for definitive radiotherapy.1 passage
• Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.1 passage
• Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.1 passage
• Two years of bicalutamide monotherapy in patients with biochemical relapse after radical prostatectomy.1 passage
• Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies.1 passage
• UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan.1 passage
• Understanding help-seeking behaviour in relation to psychosocial support services among Japanese cancer patients.1 passage
• Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.1 passage
• Uniform infection screening allowed safe head and neck surgery during the coronavirus disease 2019 pandemic in Japan.1 passage
• Unmet need for palliative rehabilitation in inpatient hospices/palliative care units: a nationwide post-bereavement survey.1 passage
• Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2.1 passage
• Update version of the Japanese Guidelines for Gastric Cancer Screening.1 passage
• Updated evidence on oncological outcomes of surgery versus external beam radiotherapy for localized prostate cancer.1 passage
• Updates in the 8th edition of the TNM staging system for esophagus and esophagogastric junction cancer.1 passage
• Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients.1 passage
• Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.1 passage
• Urologic cancer in China.1 passage
• Urologic cancer in Indonesia.1 passage
• Urologic cancer in Japan: role of Japan at the frontier of issues in Asia.1 passage
• Urologic cancer in Taiwan.1 passage
• Urologic cancer in Thailand.1 passage
• Urologic cancers in Korea.1 passage
• Urological malignancy in Hong Kong: the trend and the practice.1 passage
• Use of intensity-modulated radiation therapy for nasopharyngeal cancer in Japan: analysis using a national database.1 passage
• Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.1 passage
• Usefulness of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in elderly patients: a single-center retrospective cohort study.1 passage
• Usefulness of surgical treatment for asymptomatic patients with extra-peritoneal desmoid-type fibromatosis: a systematic review and meta-analysis.1 passage
• Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma.1 passage
• Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors.1 passage
• Utility of index lesion volume assessed by multiparametric MRI combined with Gleason grade for assessment of lymph node involvement in patients with high-risk prostate cancer.1 passage
• Utility of intraoperative frozen section examinations of surgical margins: implication of margin-exposed tumor component features on further surgical treatment.1 passage
• Utility of rapid on-site cytologic evaluation during endobronchial ultrasound with a guide sheath for peripheral pulmonary lesions.1 passage
• Validation and suggestion of eighth T classifications of the UICC/AJCC staging system for nasopharyngeal carcinoma patients: a retrospective analysis.1 passage
• Validation of the Integrated Palliative care Outcome Scale (IPOS) - Japanese Version.1 passage
• Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module.1 passage
• Validity of measuring psoas muscle mass index for assessing sarcopenia in patients with gynecological cancer.1 passage
• Validity of skeletal muscle mass index measurements for assessing sarcopenia in patients with gynecological cancer.1 passage
• Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA1/2-associated breast cancer: a case report.1 passage
• Vegetable consumption and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population.1 passage
• Venetoclax in combination with azacitidine in Japanese patients with acute myeloid leukaemia: phase 1 trial findings.1 passage
• Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.1 passage
• Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy.1 passage
• Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry.1 passage
• Viral load and integration status of HPV58 associated with cervical lesion severity in women of Northeast China.1 passage
• Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma.1 passage
• Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small-cell lung cancer.1 passage
• Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.1 passage
• What are the radiologic findings predictive of indolent lung adenocarcinoma?1 passage
• What influences the willingness of cancer patients to receive hospice palliative care at end of life?1 passage
• What is the Asian Consensus Statement on NCCN clinical practice guidelines in oncology (NCCN-ACS)?1 passage
• What is the appropriate communication style for family members confronting difficult surrogate decision-making in palliative care?: A randomized video vignette study in medical staff with working experiences of clinical oncology.1 passage
• When cancer encounters COVID-19 in China: what have we suffered, experienced and learned.1 passage
• Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy.1 passage
• Wide-spread ignorance on the treatment of subcutaneous malignant tumors; a questionnaire-based study.1 passage
• Yokukansan for the treatment of preoperative anxiety and postoperative delirium in colorectal cancer patients: a retrospective study.1 passage
• Young patients with colorectal cancer have increased risk of second primary cancers.1 passage
• miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1.1 passage
• miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1.1 passage